Geron hopes to restart stem-cell study in 2010
Biotechnology company Geron Corp. said Friday it hopes to pave the way for restarting human studies on a potential stem-cell treatment for spinal cord injury by conducting additional preclinical studies.
[Read the full article here]Related News:
Geron Starts First Human Embryonic Stem-Cell Study
Geron says FDA lifts hold on stem cell trial
Geron Starts First Human Study of Embryonic Stem-Cell Therapy